Physician profile
Nam Yu
NPI 1053516898
$1,836.58
in general payments reported to CMS, 2019-2025
14 companies · $37.27 in 2025
The $37.27 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $685 · 2021: $410 · 2022: $143 · 2023: $164 · 2024: $165 · 2025: $37.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $549.19 | 2020-2025 | Neuwave |
| Argon Medical Devices, INC. | $300.00 | 2020 | |
| Medical Device Business Services, INC. | $244.54 | 2020 | |
| Siemens Medical Solutions USA, INC. | $238.37 | 2021 | |
| Angiodynamics, INC. | $134.79 | 2019 | |
| Ge Healthcare | $133.22 | 2021 | |
| Abbvie INC. | $52.37 | 2023-2024 | Teflaro, Avycaz |
| Biocompatibles, INC. | $49.49 | 2019 | |
| Incyte Corporation | $42.20 | 2022-2024 | Monjuvi |
| Merck Sharp & Dohme LLC | $23.21 | 2024 | Keytruda |
| Boston Scientific Corporation | $21.82 | 2025 | Cryoablation Needles |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.08 | 2019 | |
| Fujifilm Wako Diagnostics U.S.A. Corporation | $16.16 | 2019 | |
| Vifor Pharma, INC. | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nam Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.